Ontology highlight
ABSTRACT:
SUBMITTER: Kaminogo K
PROVIDER: S-EPMC11246278 | biostudies-literature | 2024 Aug
REPOSITORIES: biostudies-literature
Kaminogo Kento K Yamaguchi Satoshi S Chen Hui H Yagita Hideo H Toyama Naoto N Urata Yusuke Y Hibi Hideharu H
Calcified tissue international 20240529 2
Medication-related osteonecrosis of the jaw is a serious disease occurring in patients with cancer and osteoporosis, who are undergoing treatment with antiresorptive agents (ARAs) such as bisphosphonate (BP) or denosumab, an antibody targeting receptor activator of NF-κB ligand. Recently, stem cell-based therapy has been shown to be effective in preventing the development of bisphosphonate-related osteonecrosis of the jaw. However, studies on denosumab-related osteonecrosis of the jaw (DRONJ) re ...[more]